Merger with INC Research inVentiv Health merged with INC Research to become a fully integrated biopharmaceutical solutions organization, creating potential cross-selling opportunities across a combined client base.

Financial Momentum With successful IPOs and acquisitions, including a $4.6 billion deal, inVentiv Health demonstrates financial stability, indicating potential for larger contract deals and partnerships.

Global Expansion Focus inVentiv Health's focus on meeting the needs of global biopharmaceutical firms of all sizes presents an opportunity for international sales expansion and partnerships in diverse markets.

Tech Integration Advantage inVentiv Health's integration of technology and data enhances client offerings, providing a selling point for tech-driven solutions in the competitive pharmaceutical industry.

Top Competitive Positioning Ranked among top competitors with a revenue of over $1 billion, inVentiv Health is well-positioned to target large-scale clients, showcasing capability for high-value sales engagements.